BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36675082)

  • 1. Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis.
    Plawinski L; Cras A; Hernández Lopez JR; de la Peña A; Van der Heyden A; Belle C; Toti F; Anglés-Cano E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic cross-talk: a new mechanism for plasmin formation.
    Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E
    Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
    Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
    FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles: new protagonists in pericellular and intravascular proteolysis.
    Lacroix R; Dignat-George F
    Semin Thromb Hemost; 2013 Feb; 39(1):33-9. PubMed ID: 23303566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic Activity of Circulating Microvesicles Is Associated with Progression of Breast Cancer.
    Valente-Acosta B; Flores-García M; González-Zárate G; Gerson-Cwilich R; Maldonado-Méndez M; Juárez-Vega G; Anglés-Cano E; Peña-Díaz A
    Tohoku J Exp Med; 2020 Feb; 250(2):121-128. PubMed ID: 32115494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of physiological fibrinolysis.
    Lijnen HR; Collen D
    Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.
    Lacroix R; Plawinski L; Robert S; Doeuvre L; Sabatier F; Martinez de Lizarrondo S; Mezzapesa A; Anfosso F; Leroyer AS; Poullin P; Jourde N; Njock MS; Boulanger CM; Anglés-Cano E; Dignat-George F
    Haematologica; 2012 Dec; 97(12):1864-72. PubMed ID: 22733025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.
    Leksa V; Schiller HB; Stockinger H
    Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines.
    Pontecorvi P; Banki MA; Zampieri C; Zalfa C; Azmoon P; Kounnas MZ; Marchese C; Gonias SL; Mantuano E
    J Neuroinflammation; 2019 Dec; 16(1):257. PubMed ID: 31810478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of plasmin(ogen) by bacterial pathogens of veterinary significance.
    Raymond BB; Djordjevic S
    Vet Microbiol; 2015 Jul; 178(1-2):1-13. PubMed ID: 25937317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
    Ismail AA; Shaker BT; Bajou K
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell-derived microparticles unveil their fibrinolytic and proteolytic function].
    Doeuvre L; Angles-Cano E
    Med Sci (Paris); 2009 Jan; 25(1):37-44. PubMed ID: 19154692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.
    Anglés-Cano E
    Chem Phys Lipids; 1994 Jan; 67-68():353-62. PubMed ID: 8187235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.